Pharmacokinetics of Ampreloxetine, a Norepinephrine Reuptake Inhibitor, in Healthy Subjects and Adults with Attention-Deficit/Hyperactive Disorder or Fibromyalgia Pain.
Jitendra KanodiaArthur LoR Michael BaldwinRichard A GrahamDavid L BourdetPublished in: Clinical pharmacokinetics (2021)
ClinicalTrials.gov identifier numbers NCT01693692 (fibromyalgia); NCT01458340 (attention-deficit/hyperactive disorder).